Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department

BACKGROUND: Rapid testing for COVID-19 has been clearly identified as an essential component of the strategy to control the SARS-CoV-2 epidemic, worldwide. The ID NOW COVID-19 assay is a simple, user-friendly, rapid molecular biology test based on nicking and extension amplification reaction (NEAR)....

Descripción completa

Detalles Bibliográficos
Autores principales: NguyenVan, Jean-Claude, Gerlier, Camille, Pilmis, Benoît, Mizrahi, Assaf, Péan de Ponfilly, Gauthier, Khaterchi, Amir, Enouf, Vincent, Ganansia, Olivier, Le Monnier, Alban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556064/
https://www.ncbi.nlm.nih.gov/pubmed/34768231
http://dx.doi.org/10.1016/j.jcv.2021.105021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556064/
https://www.ncbi.nlm.nih.gov/pubmed/34768231
http://dx.doi.org/10.1016/j.jcv.2021.105021

Ejemplares similares